Of Re 0.50 per share
Bliss GVS Pharma announced that the Board of Directors of the Company at its meeting held on 26 May 2014, inter alia, has recommended a final dividend of 50% i.e. Re 0.50 per equity share for the year ended 31 March 2014.Powered by Capital Market - Live News
